Market revenue in 2023 | USD 12.2 million |
Market revenue in 2030 | USD 22.3 million |
Growth rate | 9% (CAGR from 2023 to 2030) |
Largest segment | Single injection |
Fastest growing segment | Single Injection |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Single Injection, Three Injection, Five Injection |
Key market players worldwide | DePuy Synthes, Sanofi SA, Smith & Nephew PLC, Anika Therapeutics Inc, Zimmer Biomet Holdings Inc, Ferring, Lifecore Biomedical Inc, LG Chem, Roche Holding AG |
Single injection was the largest segment with a revenue share of 42.62% in 2023. Horizon Databook has segmented the South Africa viscosupplementation market based on single injection, three injection, five injection covering the revenue growth of each sub-segment from 2018 to 2030.
The South African market for viscosupplements is expected to grow owing to the aging population and improving economy. According to the estimates of Statistics South Africa, there were about 4.6 million people above the age of 60 years in the country. There is no MFN tax imposed and sales tax is 14%, with only one additional environmental tax on hyaluronic acid products, which provides a conducive environment for growth.
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
No related regions found.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account